Ultraviolet-A & Riboflavin Treatment for Infectious Keratitis

Updated 05/03/2024

Status Completed

Clinical Trial Summary

This study is to evaluate the efficacy of ultraviolet-A (UVA) and riboflavin application (also often referred to as corneal collagen crosslinking) as a method to enhance treatment of infectious keratitis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01739673
Study type	Interventional
Source	Cxlusa
Contact
Status	Completed
Phase	N/A
Start date	August 2011
Completion date	July 2014

See also
	Status	Clinical Trial	Phase
	Completed	`NCT04030403` - Investigation of the Microbiome of the Cornea in Microbial Keratitis
	Completed	`NCT04213313` - Association Between SNP of SP-D and Susceptibility and Prognosis of Infectious Keratitis
	Recruiting	`NCT02570321` - Cross-linking for Corneal Ulcers Treatment Trial	Phase 4
	Terminated	`NCT00912509` - Cross Linking for Treatment of Corneal Infection	N/A
	Completed	`NCT01831206` - Collagen Cross-linking in Infectious Keratitis Trial	Phase 2
	Completed	`NCT04383431` - Cross-linking as Treatment in Infectious Keratitis	N/A
	Recruiting	`NCT05888987` - Use of a New Method for the Microbiological Diagnosis of Severe Corneal Infection
	Not yet recruiting	`NCT03801590` - Crosslinking in Infectious Keratitis	N/A
	Recruiting	`NCT06364878` - Non-invasive Diagnostics of Microbial Keratitis
	Completed	`NCT02819232` - Microbiological Diagnosis of Infectious Keratitis to Pathogenic Fastidious Germs	N/A